Kestra Medical Technologi...

NASDAQ: KMTS · Real-Time Price · USD
16.09
0.13 (0.81%)
At close: Aug 15, 2025, 3:59 PM
16.05
-0.25%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kestra Medical Common Stock Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2024 Q3 2024 Q4 2023 Q3 2023 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Apr 30, 2024 Jan 31, 2024 Jul 31, 2021
Revenue
50.65M 33.42M 18.33M 8.28M n/a
Cost of Revenue
34.2M 24.6M 16.05M 7.4M n/a
Gross Profit
16.46M 8.82M 2.28M 880K n/a
Operating Income
-109.11M -60.9M -40.3M -19.95M -20.2M
Interest Income
2.28M 628K n/a n/a n/a
Pretax Income
-116.67M -65.66M -43.92M -21.61M -20.98M
Net Income
-117.47M -65.41M -43.9M -21.62M -21.09M
Selling & General & Admin
109.27M 58.81M 35.02M 17.09M 9.41M
Research & Development
16.3M 10.91M 7.56M 3.73M 10.78M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
125.56M 69.72M 42.57M 20.83M 20.2M
Interest Expense
7.13M 5.37M 3.59M 1.65M 847K
Selling & Marketing Expenses
n/a n/a n/a n/a 9.41M
Cost & Expenses
159.76M 94.32M 58.63M 28.22M 20.2M
Income Tax Expense
107K 5K -13K 14K 104K
Shares Outstanding (Basic)
49.53M 49.53M 49.53M 49.53M 49.53M
Shares Outstanding (Diluted)
49.53M 49.53M 49.53M 49.53M 49.53M
EPS (Basic)
-3.63 -1.42 -0.92 -0.47 -0.43
EPS (Diluted)
-3.63 -1.42 -0.92 -0.47 -0.43
EBITDA
-98.95M -51.53M -33.47M -16.59M -19.94M
EBIT
-109.54M -60.29M -40.33M -19.95M -20.14M
Depreciation & Amortization
10.59M 8.75M 6.87M 3.36M 192K